Publications by authors named "Hannah Chaudry"
A Novel Microcatheter Enters the Chronic Total Occlusion Space: An Advancement or Just Another Device?
J Soc Cardiovasc Angiogr Interv
July 2024
Times up to demonstrate a difference is current DES platforms.
Catheter Cardiovasc Interv
December 2020
Current generation durable polymer DES have sustained efficacy and safety out to 5 years. The Orsiro DES has both a bioresorbable polymer and ultra thin struts and has the potential to improve the safety of DES. In this all comers trial, 3 year outcomes with Orsiro DES were similar to the durable polymer zotarolimus eluting stent.
View Article and Find Full Text PDFArticle Synopsis
- * A study analyzed data from 15,284 PCI cases between 2003 and 2016, revealing significant decreases in bleeding and vascular complications for both men and women, with the improvements being more pronounced in women.
- * While the overall rates of complications have improved and the gender gap has narrowed, women still experience higher bleeding rates than men post-PCI as of 2016.
Background: Very elderly patients (age ≥ 85 years) are a rapidly increasing segment of the population. As a group, they experience high rates of in-hospital mortality and bleeding complications following percutaneous coronary intervention (PCI). However, the relationship between bleeding and mortality in the very elderly is unknown.
View Article and Find Full Text PDFObjective: The choice of antithrombotic agent used during percutaneous coronary intervention (PCI) is controversial. While earlier studies suggested a reduction in bleeding events with bivalirudin, these studies were confounded by the concomitant use of glycoprotein IIbIIIa inhibitors (GPI) in the heparin group. More recent studies have challenged the superiority of bivalirudin, pointing to an increased risk of stent thrombosis.
View Article and Find Full Text PDFBackground: To determine whether exercise performance changed over time once patients stabilized after heart transplantation, metabolic stress testing was performed in patients one and two yr post-heart transplantation.
Methods: The patient cohort includes those transplanted in our program who survived at least two yr and were able to perform metabolic stress tests during their one- and two-yr annual evaluations. Standard stress test parameters were assessed, including weight, body surface area, rest and exercise heart rate (HR) and blood pressure (BP), exercise time, anaerobic threshold (AT), and maximum VO2 (MVO2).